DIFFERENTIAL-EFFECTS OF CD4+ AND CD8+ CELLS IN ACUTE, SYSTEMIC MURINE CANDIDOSIS

被引:27
作者
COKER, LA
MERCADAL, CM
ROUSE, BT
MOORE, RN
机构
[1] UNIV TENNESSEE,COLL LIBERAL ARTS,DEPT MICROBIOL,KNOXVILLE,TN 37996
[2] UNIV TENNESSEE,COLL VET MED,KNOXVILLE,TN 37996
关键词
CANDIDA ALBICANS; MONOCLONAL ANTIBODY DEPLETION; IMMUNOPATHOLOGY;
D O I
10.1002/jlb.51.3.305
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Monoclonal antibody (mAb) depletion was used to assess contributions of CD4+ and CD8+ cells in resistance to systemic murine Candida albicans infection. Depletion of CD8+ cells did not influence either survival or mean survival time (MST); however, depletion of CD4+ cells significantly enhanced both survival and MST. Combined depletion of both CD4+ and CD8+ cells significantly lengthened the MST but did not enhance survival. A protective influence of CD8+ cells could be deduced but, to be manifested, required depletion of an overshadowing immunopathologic CD4+ response.
引用
收藏
页码:305 / 306
页数:2
相关论文
共 14 条
  • [1] CORRELATES OF CELL-MEDIATED-IMMUNITY IN CANDIDA-ALBICANS-COLONIZED GNOTOBIOTIC MICE
    BALISH, E
    FILUTOWICZ, H
    OBERLEY, TD
    [J]. INFECTION AND IMMUNITY, 1990, 58 (01) : 107 - 113
  • [2] ROLE OF L3T4+ LYMPHOCYTES IN PROTECTIVE IMMUNITY TO SYSTEMIC CANDIDA-ALBICANS INFECTION IN MICE
    CENCI, E
    ROMANI, L
    VECCHIARELLI, A
    PUCCETTI, P
    BISTONI, F
    [J]. INFECTION AND IMMUNITY, 1989, 57 (11) : 3581 - 3587
  • [3] INDUCTION OF SUPPRESSOR CELLS-INVITRO BY CANDIDA-ALBICANS
    CUFF, CF
    ROGERS, CM
    LAMB, BJ
    ROGERS, TJ
    [J]. CELLULAR IMMUNOLOGY, 1986, 100 (01) : 47 - 56
  • [4] CUTLER JE, RES J RETICULOENDETH, V19, P121
  • [5] DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
  • [6] DJEU JY, 1988, J IMMUNOL, V141, P4047
  • [7] ELIMINATION OF CD4+ SUPPRESSOR T-CELLS FROM SUSCEPTIBLE BALB/C MICE RELEASES CD8+ LYMPHOCYTE-T TO MEDIATE PROTECTIVE IMMUNITY AGAINST LEISHMANIA
    HILL, JO
    AWWAD, M
    NORTH, RJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) : 1819 - 1827
  • [8] MATTHEWS R, 1988, LANCET, V2, P263
  • [9] PEARSALL NN, 1978, J IMMUNOL, V120, P1176
  • [10] ROGERS TJ, 1976, J RETICULOENDOTH SOC, V20, P291